Clover Biopharmaceuticals Implements Full Electronic Dissemination of Corporate Communications, Seeks Shareholders’ Email Details

Bulletin Express04-23 19:03

Clover Biopharmaceuticals, Ltd. has reiterated its transition to electronic dissemination of all corporate communications, following earlier announcements dated 27 March 2024, 20 June 2024 and 19 September 2024.

All future documents—including annual and interim reports, meeting notices, listing documents, circulars, reply slips and proxy forms—will be published in both English and Chinese on the company’s website (www.cloverbiopharma.com) and on the HKEX news platform (www.hkexnews.hk). Printed copies will cease unless specifically requested.

Registered shareholders who have not yet provided an email address are urged to submit one by scanning the personalised QR code on the reply form or by returning the form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. Alternatively, shareholders may email clover.ecom@computershare.com.hk.

If no functional email address is supplied, Clover Biopharmaceuticals will continue to mail printed versions of Actionable Corporate Communications to the shareholder’s registered address until valid contact details are received.

Shareholders preferring hard-copy documents may opt in by completing and returning the reply form or emailing their request. Each such election remains effective for one year unless revoked or superseded.

Enquiries can be directed to Computershare Hong Kong Investor Services Limited on +852 2862 8688 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180258474?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180258474","market":"us","top_or_hot":-1,"title":"Clover Biopharmaceuticals Implements Full Electronic Dissemination of Corporate Communications, Seeks Shareholders’ Email Details","media":"Bulletin Express","content":"<p>Clover Biopharmaceuticals, Ltd. has reiterated its transition to electronic dissemination of all corporate communications, following earlier announcements dated 27 March 2024, 20 June 2024 and 19 September 2024.</p>\n<p>All future documents—including annual and interim reports, meeting notices, listing documents, circulars, reply slips and proxy forms—will be published in both English and Chinese on the company’s website (www.cloverbiopharma.com) and on the HKEX news platform (www.hkexnews.hk). Printed copies will cease unless specifically requested.</p>\n<p>Registered shareholders who have not yet provided an email address are urged to submit one by scanning the personalised QR code on the reply form or by returning the form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. Alternatively, shareholders may email clover.ecom@computershare.com.hk.</p>\n<p>If no functional email address is supplied, Clover Biopharmaceuticals will continue to mail printed versions of Actionable Corporate Communications to the shareholder’s registered address until valid contact details are received.</p>\n<p>Shareholders preferring hard-copy documents may opt in by completing and returning the reply form or emailing their request. Each such election remains effective for one year unless revoked or superseded.</p>\n<p>Enquiries can be directed to Computershare Hong Kong Investor Services Limited on +852 2862 8688 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Biopharmaceuticals Implements Full Electronic Dissemination of Corporate Communications, Seeks Shareholders’ Email Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Biopharmaceuticals Implements Full Electronic Dissemination of Corporate Communications, Seeks Shareholders’ Email Details\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Clover Biopharmaceuticals, Ltd. has reiterated its transition to electronic dissemination of all corporate communications, following earlier announcements dated 27 March 2024, 20 June 2024 and 19 September 2024.</p>\n<p>All future documents—including annual and interim reports, meeting notices, listing documents, circulars, reply slips and proxy forms—will be published in both English and Chinese on the company’s website (www.cloverbiopharma.com) and on the HKEX news platform (www.hkexnews.hk). Printed copies will cease unless specifically requested.</p>\n<p>Registered shareholders who have not yet provided an email address are urged to submit one by scanning the personalised QR code on the reply form or by returning the form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. Alternatively, shareholders may email clover.ecom@computershare.com.hk.</p>\n<p>If no functional email address is supplied, Clover Biopharmaceuticals will continue to mail printed versions of Actionable Corporate Communications to the shareholder’s registered address until valid contact details are received.</p>\n<p>Shareholders preferring hard-copy documents may opt in by completing and returning the reply form or emailing their request. Each such election remains effective for one year unless revoked or superseded.</p>\n<p>Enquiries can be directed to Computershare Hong Kong Investor Services Limited on +852 2862 8688 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02197","symbol_name":"三叶草生物-B","start_time":0,"source_url":"","article_id":"1180258474","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180258474","pubTimestamp":1776942238,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Clover Biopharmaceuticals, Ltd. has reiterated its transition to electronic dissemination of all corporate communications, following earlier announcements dated 27 March 2024, 20 June 2024 and 19...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02197":"三叶草生物-B"},"translate_title":"Clover Biopharmaceuticals实施公司通讯全面电子化传播，寻求股东电子邮件详细信息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1},"content_text":"Clover Biopharmaceuticals, Ltd. has reiterated its transition to electronic dissemination of all corporate communications, following earlier announcements dated 27 March 2024, 20 June 2024 and 19 September 2024.\nAll future documents—including annual and interim reports, meeting notices, listing documents, circulars, reply slips and proxy forms—will be published in both English and Chinese on the company’s website (www.cloverbiopharma.com) and on the HKEX news platform (www.hkexnews.hk). Printed copies will cease unless specifically requested.\nRegistered shareholders who have not yet provided an email address are urged to submit one by scanning the personalised QR code on the reply form or by returning the form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited. Alternatively, shareholders may email clover.ecom@computershare.com.hk.\nIf no functional email address is supplied, Clover Biopharmaceuticals will continue to mail printed versions of Actionable Corporate Communications to the shareholder’s registered address until valid contact details are received.\nShareholders preferring hard-copy documents may opt in by completing and returning the reply form or emailing their request. Each such election remains effective for one year unless revoked or superseded.\nEnquiries can be directed to Computershare Hong Kong Investor Services Limited on +852 2862 8688 between 9:00 a.m. and 6:00 p.m. (Hong Kong time), Monday to Friday, excluding public holidays.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180258474","isCrawlerRequest":true}